These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 32570036

  • 1. Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats.
    Zhang J, Yi T, Cheng S, Zhang S.
    Int Immunopharmacol; 2020 Sep; 86():106715. PubMed ID: 32570036
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway.
    Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y, Gao R, Chen G.
    Brain Res Bull; 2018 Jun; 140():154-161. PubMed ID: 29698747
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exendin-4 reverses high glucose-induced endothelial progenitor cell dysfunction via SDF-1β/CXCR7-AMPK/p38-MAPK/IL-6 axis.
    Yang Y, Zhou Y, Wang Y, Wei X, Wu L, Wang T, Ma A.
    Acta Diabetol; 2020 Nov; 57(11):1315-1326. PubMed ID: 32556532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.
    Rachmany L, Tweedie D, Li Y, Rubovitch V, Holloway HW, Miller J, Hoffer BJ, Greig NH, Pick CG.
    Age (Dordr); 2013 Oct; 35(5):1621-36. PubMed ID: 22892942
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury.
    Liu ZK, Ng CF, Shiu HT, Wong HL, Chin WC, Zhang JF, Lam PK, Poon WS, Lau CB, Leung PC, Ko CH.
    J Ethnopharmacol; 2018 May 10; 217():11-22. PubMed ID: 29425850
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury.
    Li Y, Glotfelty EJ, Namdar I, Tweedie D, Olson L, Hoffer BJ, DiMarchi RD, Pick CG, Greig NH.
    Exp Neurol; 2020 Feb 10; 324():113113. PubMed ID: 31730763
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.
    Bader M, Li Y, Lecca D, Rubovitch V, Tweedie D, Glotfelty E, Rachmany L, Kim HK, Choi HI, Hoffer BJ, Pick CG, Greig NH, Kim DS.
    Neurobiol Dis; 2019 Apr 10; 124():439-453. PubMed ID: 30471415
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of FK866 against traumatic brain injury: Involvement of p38/ERK pathway.
    Tan Z, Chen L, Ren Y, Jiang X, Gao W.
    Ann Clin Transl Neurol; 2020 May 10; 7(5):742-756. PubMed ID: 32302063
    [Abstract] [Full Text] [Related]

  • 19. 3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury.
    Huang PS, Tsai PY, Yang LY, Lecca D, Luo W, Kim DS, Hoffer BJ, Chiang YH, Greig NH, Wang JY.
    Int J Mol Sci; 2021 Jul 31; 22(15):. PubMed ID: 34361041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.